Trials / Conditions / Adult Acute Erythroid Leukemia (M6)
Adult Acute Erythroid Leukemia (M6)
5 registered clinical trials studyying Adult Acute Erythroid Leukemia (M6).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome NCT02019069 | Rondeep Brar | Phase 2 |
| Completed | Vorinostat in Treating Patients With Acute Myeloid Leukemia NCT00305773 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia NCT00101296 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia NCT00027872 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 i NCT00006363 | National Cancer Institute (NCI) | Phase 3 |